✦ LIBER ✦

18F-labeled radiopharmaceuticals for PET in oncology, excluding FDG

✍ Scribed by L. Varagnolo; M.P.M Stokkel; U. Mazzi; E.K.J Pauwels

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Non-[18F]FDG PET in clinical oncology

✍ Ashley M Groves; Thida Win; Simona Ben Haim; Peter J Ell 📂 Article 📅 2007 🏛 The Lancet 🌐 English ⚖ 503 KB

Fluorine-18 radiopharmaceuticals beyond

✍ H.H. Coenen; P.H. Elsinga; R. Iwata; M.R. Kilbourn; M.R.A. Pillai; M.G.R. Rajan; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 293 KB

Guidelines for18F-FDG PET and PET-CT ima

✍ J. Stauss; C. Franzius; T. Pfluger; K. U. Juergens; L. Biassoni; J. Begent; R. K 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 141 KB

Guidelines for18F-FDG PET and PET-CT ima

✍ J. Stauss; C. Franzius; T. Pfluger; K. U. Juergens; L. Biassoni; J. Begent; R. K 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 42 KB

Support for Warburg’s hypothesis using d

✍ Ingeborg Goethals; Simon Hanssens; Koen Kortbeek; Peter Smeets; Simon Van Belle; 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 69 KB

PET radiopharmaceuticals for metabolic i

✍ Leonard I Wiebe 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 504 KB